Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 545

1.

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:.

J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.

PMID:
30234752
2.

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.

Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder RE.

Cardiovasc Diabetol. 2018 Sep 19;17(1):128. doi: 10.1186/s12933-018-0770-4.

3.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available.

PMID:
30165516
4.

Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up.

Jung S, Ott C, Karg MV, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder RE.

J Hypertens. 2018 Aug 14. doi: 10.1097/HJH.0000000000001873. [Epub ahead of print]

PMID:
30113527
5.

European Society of Hypertension position paper on renal denervation 2018.

Schmieder RE, Mahfoud F, Azizi M, Pathak A, Dimitriadis K, Kroon AA, Ott C, Scalise F, Mancia G, Tsioufis C; Members of the ESH Working Group on Interventional Treatment of Hypertension.

J Hypertens. 2018 Oct;36(10):2042-2048. doi: 10.1097/HJH.0000000000001858.

PMID:
30015759
6.

Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success.

Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL, Gupta A, Balawon A, Pheby J, Zak A, Rull G, O'Brien B, Schmieder RE, Lobo MD.

J Am Heart Assoc. 2018 Jun 12;7(12). pii: e009151. doi: 10.1161/JAHA.118.009151.

7.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators.

Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Erratum in: Lancet. 2018 Sep 8;392(10150):820.

PMID:
29803590
8.

Correction to: Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Apr 9;20(3):27. doi: 10.1007/s11906-018-0844-4.

PMID:
29629502
9.

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP.

Microvasc Res. 2018 Jul;118:121-127. doi: 10.1016/j.mvr.2018.03.008. Epub 2018 Mar 17.

PMID:
29559377
10.

Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Mar 19;20(3):18. doi: 10.1007/s11906-018-0816-8. Review. Erratum in: Curr Hypertens Rep. 2018 Apr 9;20(3):27.

PMID:
29556742
11.

Renal denervation improves 24-hour central and peripheral blood pressures, arterial stiffness, and peripheral resistance.

Ott C, Franzen KF, Graf T, Weil J, Schmieder RE, Reppel M, Mortensen K.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):366-372. doi: 10.1111/jch.13193. Epub 2018 Jan 25.

12.

Individualised treatment targets in patients with type-2 diabetes and hypertension.

Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK; DIALOGUE study group.

Cardiovasc Diabetol. 2018 Jan 22;17(1):18. doi: 10.1186/s12933-018-0661-8.

13.

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.

Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE.

Cardiovasc Diabetol. 2018 Jan 4;17(1):5. doi: 10.1186/s12933-017-0654-z.

14.

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE.

BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x.

15.

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.

Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M.

Am Heart J. 2018 Jan;195:115-129. doi: 10.1016/j.ahj.2017.09.006. Epub 2017 Sep 12.

PMID:
29224639
16.

Central arteriovenous anastomosis to treat resistant hypertension.

Kapil V, Sobotka PA, Lobo MD, Schmieder RE.

Curr Opin Nephrol Hypertens. 2018 Jan;27(1):8-15. doi: 10.1097/MNH.0000000000000379. Review.

PMID:
29084002
17.

Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial.

Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE.

Hypertension. 2017 Dec;70(6):1099-1105. doi: 10.1161/HYPERTENSIONAHA.117.10142. Epub 2017 Oct 23.

PMID:
29061728
18.

Retinal vascular resistance in arterial hypertension.

Kannenkeril D, Harazny JM, Bosch A, Ott C, Michelson G, Schmieder RE, Friedrich S.

Blood Press. 2018 Apr;27(2):82-87. doi: 10.1080/08037051.2017.1393311. Epub 2017 Oct 23.

PMID:
29057671
19.

Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV.

Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Ormiston J, Saxena M, Sharp ASP, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo MD.

J Hypertens. 2018 Mar;36(3):680-689. doi: 10.1097/HJH.0000000000001584.

PMID:
29035942
20.

The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.

Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Hrabak-Paar M, Heye T, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J.

Eur Heart J. 2017 Nov 21;38(44):3308-3317. doi: 10.1093/eurheartj/ehx525.

PMID:
29029087

Supplemental Content

Loading ...
Support Center